Published in PLoS One on June 29, 2012
The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe (2014) 7.43
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol (2012) 5.66
Human genetics shape the gut microbiome. Cell (2014) 4.91
The intestinal microbiome in early life: health and disease. Front Immunol (2014) 1.90
Medicines from microbiota. Nat Biotechnol (2013) 1.72
Meta-analyses of human gut microbes associated with obesity and IBD. FEBS Lett (2014) 1.57
Ablation of tumor necrosis factor is associated with decreased inflammation and alterations of the microbiota in a mouse model of inflammatory bowel disease. PLoS One (2015) 1.47
Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol Syst Biol (2014) 1.44
Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission. ISME J (2014) 1.38
Distribution-based clustering: using ecology to refine the operational taxonomic unit. Appl Environ Microbiol (2013) 1.25
Alterations in the colonic microbiota in response to osmotic diarrhea. PLoS One (2013) 1.16
Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease. J Crohns Colitis (2015) 1.15
Characteristics of fecal and mucosa-associated microbiota in Chinese patients with inflammatory bowel disease. Medicine (Baltimore) (2014) 1.03
Gut microbiota signatures predict host and microbiota responses to dietary interventions in obese individuals. PLoS One (2014) 1.00
Multiphasic analysis of the temporal development of the distal gut microbiota in patients following ileal pouch anal anastomosis. Microbiome (2013) 0.96
Irritable bowel syndrome, inflammatory bowel disease and the microbiome. Curr Opin Endocrinol Diabetes Obes (2014) 0.95
Metagenomic predictions: from microbiome to complex health and environmental phenotypes in humans and cattle. PLoS One (2013) 0.94
Characterization of adherent bacteroidales from intestinal biopsies of children and young adults with inflammatory bowel disease. PLoS One (2013) 0.93
Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome. Microbiome (2016) 0.88
Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease. World J Gastroenterol (2014) 0.87
Mucosal healing and deep remission: what does it mean? World J Gastroenterol (2013) 0.87
Exploring the influence of the gut microbiota and probiotics on health: a symposium report. Br J Nutr (2014) 0.86
Natural bacterial communities serve as quantitative geochemical biosensors. MBio (2015) 0.85
The multifaceted role of commensal microbiota in homeostasis and gastrointestinal diseases. J Immunol Res (2015) 0.84
Implications of the human microbiome project for epidemiology. Am J Epidemiol (2013) 0.83
Age-dependent fecal bacterial correlation to inflammatory bowel disease for newly diagnosed untreated children. Gastroenterol Res Pract (2013) 0.82
Altered intestinal microbiota-host mitochondria crosstalk in new onset Crohn's disease. Nat Commun (2016) 0.82
Pathogenesis of Crohn's disease. F1000Prime Rep (2015) 0.81
Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease. Genome Med (2016) 0.80
IBS and IBD - separate entities or on a spectrum? Nat Rev Gastroenterol Hepatol (2016) 0.79
The Immune Response to Prevotella Bacteria in Chronic Inflammatory Disease. Immunology (2017) 0.77
Explaining diversity in metagenomic datasets by phylogenetic-based feature weighting. PLoS Comput Biol (2015) 0.77
Detecting Microbial Dysbiosis Associated with Pediatric Crohn Disease Despite the High Variability of the Gut Microbiota. Cell Rep (2016) 0.77
Microbiome analysis - from technical advances to biological relevance. F1000Prime Rep (2014) 0.76
Involvement of Reduced Microbial Diversity in Inflammatory Bowel Disease. Gastroenterol Res Pract (2016) 0.76
Genetic and functional profiling of Crohn's disease: autophagy mechanism and susceptibility to infectious diseases. Biomed Res Int (2013) 0.76
NASPGHAN single-topic symposium: discovering the future of pediatric IBD care. J Pediatr Gastroenterol Nutr (2014) 0.75
Rebooting the microbiome. Gut Microbes (2016) 0.75
Unraveling the processes shaping mammalian gut microbiomes over evolutionary time. Nat Commun (2017) 0.75
The fecal microbiota as a biomarker for disease activity in Crohn's disease. Sci Rep (2016) 0.75
The role of the innate and adaptive immune system in pediatric inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.75
Early-Life Sugar Consumption Affects the Rat Microbiome Independently of Obesity. J Nutr (2016) 0.75
Microbiomarkers in inflammatory bowel diseases: caveats come with caviar. Gut (2017) 0.75
Interpretation of microbiota-based diagnostics by explaining individual classifier decisions. BMC Bioinformatics (2017) 0.75
16S sequencing and functional analysis of the fecal microbiome during treatment of newly diagnosed pediatric inflammatory bowel disease. Medicine (Baltimore) (2017) 0.75
Statistical significance for genomewide studies. Proc Natl Acad Sci U S A (2003) 88.64
Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol (2007) 60.97
The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res (2008) 52.43
An integrated genomic analysis of human glioblastoma multiforme. Science (2008) 51.36
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A (2007) 20.60
Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res (2011) 17.21
Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med (2002) 14.01
A review of feature selection techniques in bioinformatics. Bioinformatics (2007) 13.51
Microbial influences in inflammatory bowel diseases. Gastroenterology (2008) 9.20
The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol (2008) 7.91
Evaluating different approaches that test whether microbial communities have the same structure. ISME J (2008) 7.70
Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc Natl Acad Sci U S A (2005) 6.54
Inflammatory bowel disease: cause and immunobiology. Lancet (2007) 6.07
Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease. Gastroenterology (2007) 5.40
A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology (2010) 5.29
Dysbiosis in inflammatory bowel disease. Gut (2004) 5.01
Guidelines for the management of inflammatory bowel disease in adults. Gut (2004) 4.15
Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology (2005) 4.10
Support vector machines and kernels for computational biology. PLoS Comput Biol (2008) 3.16
Cancer risk and life expectancy of children with ulcerative colitis. N Engl J Med (1971) 3.10
Molecular analysis of the gut microbiota of identical twins with Crohn's disease. ISME J (2008) 2.96
Machine learning and its applications to biology. PLoS Comput Biol (2007) 2.57
Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology (1998) 2.38
The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease. Gastroenterology (2011) 2.18
Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol (2001) 2.06
Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease. Inflamm Bowel Dis (2007) 1.63
Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases. Gut (2008) 1.54
Current diagnosis, management and morbidity in paediatric inflammatory bowel disease. Acta Paediatr (2001) 1.30
Microbial host interactions in IBD: implications for pathogenesis and therapy. Curr Gastroenterol Rep (2007) 1.22
Performance of blood tests in diagnosis of inflammatory bowel disease in a specialist clinic. Arch Dis Child (2004) 1.18
Appraisal of the pediatric ulcerative colitis activity index (PUCAI). Inflamm Bowel Dis (2009) 1.18
Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease. Am J Gastroenterol (2001) 1.17
A review of activity indices and end points for clinical trials in children with Crohn's disease. Inflamm Bowel Dis (2005) 1.13
Diagnostic difficulties in inflammatory bowel disease pathology. Histopathology (2006) 1.10
High diagnostic value of 18F-FDG-PET in pediatric patients with chronic inflammatory bowel disease. Ann N Y Acad Sci (2006) 1.07
Innate and adaptive immune responses related to IBD pathogenesis. Curr Gastroenterol Rep (2007) 1.03
Appraisal of the pediatric Crohn's disease activity index on four prospectively collected datasets: recommended cutoff values and clinimetric properties. Am J Gastroenterol (2010) 1.01
Presenting symptoms and diagnostic lag in children with inflammatory bowel disease. Inflamm Bowel Dis (1999) 0.95
Nutritional concerns in pediatric inflammatory bowel disease patients. Mol Nutr Food Res (2008) 0.91
Multi-detector CT-colonography in inflammatory bowel disease: prospective analysis of CT-findings to high-resolution video colonoscopy. Eur J Radiol (2005) 0.87
A general method to derive robust organ-specific gene expression-based differentiation indices: application to thyroid cancer diagnostic. Oncogene (2012) 0.87
Probiotics: do they help to control intestinal inflammation? Ann N Y Acad Sci (2006) 0.84
A critical evaluation of serologic markers for inflammatory bowel disease. Clin Gastroenterol Hepatol (2007) 0.82
Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature (2007) 65.18
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet (2008) 30.20
Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat Biotechnol (2009) 27.17
Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature (2005) 23.04
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet (2007) 19.08
Evolution of genes and genomes on the Drosophila phylogeny. Nature (2007) 18.01
Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res (2011) 17.21
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature (2012) 16.13
Identification of host proteins required for HIV infection through a functional genomic screen. Science (2008) 12.44
Reducing the effects of PCR amplification and sequencing artifacts on 16S rRNA-based studies. PLoS One (2011) 12.26
Metagenomic biomarker discovery and explanation. Genome Biol (2011) 11.29
A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature (2008) 10.84
Quality scores and SNP detection in sequencing-by-synthesis systems. Genome Res (2008) 10.49
Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat Genet (2008) 9.52
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature (2009) 8.71
Identifying relationships among genomic disease regions: predicting genes at pathogenic SNP associations and rare deletions. PLoS Genet (2009) 8.39
A catalog of reference genomes from the human microbiome. Science (2010) 8.10
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet (2011) 7.98
The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell (2009) 7.88
Genetics and pathogenesis of inflammatory bowel disease. Nature (2011) 7.79
Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell (2008) 7.61
Minimum information about a marker gene sequence (MIMARKS) and minimum information about any (x) sequence (MIxS) specifications. Nat Biotechnol (2011) 7.53
Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med (2004) 6.77
Metabolic reconstruction for metagenomic data and its application to the human microbiome. PLoS Comput Biol (2012) 6.27
Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology. PLoS Genet (2011) 6.20
The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol (2007) 6.19
IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest (2008) 6.17
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res (2011) 5.97
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol (2012) 5.66
Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet (2011) 5.58
Quality-filtering vastly improves diversity estimates from Illumina amplicon sequencing. Nat Methods (2012) 5.41
Microbial co-occurrence relationships in the human microbiome. PLoS Comput Biol (2012) 5.35
SNP genotyping using the Sequenom MassARRAY iPLEX platform. Curr Protoc Hum Genet (2009) 5.01
RNA interference screen for human genes associated with West Nile virus infection. Nature (2008) 4.93
Unlocking short read sequencing for metagenomics. PLoS One (2010) 4.88
A novel method for accurate operon predictions in all sequenced prokaryotes. Nucleic Acids Res (2005) 4.68
Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples. Genome Biol (2012) 4.68
Population genomics of early events in the ecological differentiation of bacteria. Science (2012) 4.67
Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat Genet (2010) 4.65
MicrobesOnline: an integrated portal for comparative and functional genomics. Nucleic Acids Res (2009) 4.32
A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. Cell Host Microbe (2009) 4.24
A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. Gastroenterology (2013) 4.06
Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology (2011) 3.84
Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet (2009) 3.82
Inferring correlation networks from genomic survey data. PLoS Comput Biol (2012) 3.80
Ecology drives a global network of gene exchange connecting the human microbiome. Nature (2011) 3.64
Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci U S A (2012) 3.62
Resource partitioning and sympatric differentiation among closely related bacterioplankton. Science (2008) 3.46
Sequence-based discovery of Bradyrhizobium enterica in cord colitis syndrome. N Engl J Med (2013) 3.39
A genome-wide genetic screen for host factors required for hepatitis C virus propagation. Proc Natl Acad Sci U S A (2009) 3.37
Impaired autophagy of an intracellular pathogen induced by a Crohn's disease associated ATG16L1 variant. PLoS One (2008) 3.36
Tracking insertion mutants within libraries by deep sequencing and a genome-wide screen for Haemophilus genes required in the lung. Proc Natl Acad Sci U S A (2009) 3.35
Experimental and analytical tools for studying the human microbiome. Nat Rev Genet (2011) 3.30
DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J Clin Invest (2008) 3.17
Efficient and robust RNA-seq process for cultured bacteria and complex community transcriptomes. Genome Biol (2012) 3.02
Host lifestyle affects human microbiota on daily timescales. Genome Biol (2014) 2.99
The bacterial species challenge: making sense of genetic and ecological diversity. Science (2009) 2.88
Risks and benefits of infliximab for the treatment of Crohn's disease. Clin Gastroenterol Hepatol (2006) 2.88
IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans. Proc Natl Acad Sci U S A (2014) 2.86
A scalable, fully automated process for construction of sequence-ready barcoded libraries for 454. Genome Biol (2010) 2.79
The African coelacanth genome provides insights into tetrapod evolution. Nature (2013) 2.78
Treatment of active Crohn's disease with recombinant human granulocyte-macrophage colony-stimulating factor. Lancet (2002) 2.74
An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia. Nucleic Acids Res (2009) 2.69
Risk factors, morbidity, and treatment of thrombosis in children and young adults with active inflammatory bowel disease. J Pediatr Gastroenterol Nutr (2013) 2.65
A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women. Am J Gastroenterol (2012) 2.63
The complete genome sequence of the carcinogenic bacterium Helicobacter hepaticus. Proc Natl Acad Sci U S A (2003) 2.62
Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov. Int J Syst Evol Microbiol (2009) 2.61
Image-based genome-wide siRNA screen identifies selective autophagy factors. Nature (2011) 2.58
Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study. Clin Infect Dis (2014) 2.41
A genome-wide siRNA screen reveals multiple mTORC1 independent signaling pathways regulating autophagy under normal nutritional conditions. Dev Cell (2010) 2.40
Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. J Clin Invest (2014) 2.39
Rapid evolutionary innovation during an Archaean genetic expansion. Nature (2010) 2.34
Autosis is a Na+,K+-ATPase-regulated form of cell death triggered by autophagy-inducing peptides, starvation, and hypoxia-ischemia. Proc Natl Acad Sci U S A (2013) 2.33
Ubiquitin accumulation in autophagy-deficient mice is dependent on the Nrf2-mediated stress response pathway: a potential role for protein aggregation in autophagic substrate selection. J Cell Biol (2010) 2.32
Dissimilatory metabolism of nitrogen oxides in bacteria: comparative reconstruction of transcriptional networks. PLoS Comput Biol (2005) 2.27
Crohn's disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly. Cell Microbiol (2009) 2.23
CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice. Cancer Res (2005) 2.20
The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it matters. FASEB J (2012) 2.13
Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer's disease. Proc Natl Acad Sci U S A (2010) 2.10
Stressor exposure disrupts commensal microbial populations in the intestines and leads to increased colonization by Citrobacter rodentium. Infect Immun (2010) 2.06
A metagenomic approach to characterization of the vaginal microbiome signature in pregnancy. PLoS One (2012) 1.98
Environmental genomics reveals a single-species ecosystem deep within Earth. Science (2008) 1.98
Evaluation of the pediatric crohn disease activity index: a prospective multicenter experience. J Pediatr Gastroenterol Nutr (2005) 1.98